The cosmetic industry has a history of constant modernization, with products that are increasingly sustainable and well tolerated by the customers. In the last years, the growing understanding and knowledge of the potential of marine species, as well as the application of “blue biotechnology” have been motivating new innovative solutions in this area. Marine organisms are important sources of compounds that may be applicable in cosmetics, with biological activities that include depigmentant, anti-aging or anti-bacterial properties, specifically against acne, but also as formulation promoters and facilitators. Several methods can be used to extract these molecules, but these are not free of challenges and implications – possible biological and chemical contamination, and problems with batch reproducibility, which can be associated to the intraspecific variability of the different specimens, should be considered. Alongside these, the legislative and normative framework is increasingly developed and there is a growing concern with this situation. The application of sustainability fundamentals in the production of cosmetics must respect a life cycle approach, critically analyzing each stage. In this sense, “blue biotechnology”, in constant evolution, together with the use of invasive species or marine waste products to obtain new active ingredients, emerge as innovative and sustainable solutions for the future’s cosmetics industry. This review explores various biological properties of marine-derived molecules and discusses the challenges and implications associated with extracting these compounds. It also examines recent advancements in 'blue biotechnology' and their relevance to the sustainable development of innovative cosmetics.

The present work consisted of an exploratory study aiming to evaluate in vitro the potential of AuNPs during Radiation Therapy (RT) in human pancreatic adenocarcinoma cells. AuNPs coated with hyaluronic and oleic acids (HAOA-AuNPs) or with bombesin peptides (BBN-AuNPs) were used. AuNPs were characterized by Atomic Force Microscopy (AFM) and Dynamic Light Scattering. BxPC-3 tumour cells were irradiated with a 6 MV X-rays beam, in the absence or presence of AuNPs. AFM showed that HAOA-AuNPs and BBN-AuNPs are spherical with a mean size of 83+-20 nm and 49+-12 nm, respectively. For RT alone, a reduction in cell viability of up to 33+-12% was obtained compared to the control (p ≤ 0.0001). HAOA-AuNPs alone at 200 and 400 μM showed a reduction in cell viability of 20+-4% and 35+-4%, respectively, while for BBN-AuNPs, at 50 and 200 μM, a reduction in cell viability of 25+-3% and 37+-3% was obtained, respectively, compared to the control (p < 0.0001). At 72 h post-irradiation, a decrease in cell viability of 26+-3% and 22+-2% between RT+HAOA-AuNPs at 400 μM and RT+BBN-AuNPs at 50 μM, compared to RT alone, was obtained (p < 0.004). The combination of RT with AuNPs led to a significant decrease in cell viability compared to the control, or RT alone, thus representing an improved effect.